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A cDNA (912 nucleotides) coding for human plasma sex steroid-binding protein (SBP) was characterized 
from a phage clone previously isolated by screening a Charon 21A human liver cDNA library with rat an- 
drogen binding protein (ABP) cDNA. The deduced amino acid sequence from the cDNA indicated that 
the insert was a partial clone coding for 281 amino acids starting with residue 92 (glycine) encompassing 
the alternating leucyl residues and the carboxyl-end 373 (histidine) as previously reported [( 1986) Biochemis- 
try 25, 75841. The potential polyadenylation signal sequence ATTAAA is present as part of the 3’-coding 
region and the stop codon TAA. Both are followed by a short 20 untranslated nucleotides and a poly(A) 
tract of 49 nucleotides. Significant homologous sequences (76%) at the DNA level exist between human SBP 
and rat ABP which might suggest he possibility that both evolved from a common primordial gene. Dem- 
onstration of the presence of an SBP cDNA in a human liver cDNA library provides the first evidence that 
liver is the site of SBP biosynthesis. 
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1. INTRODUCTION 
Human plasma sex steroid-binding protein 
(hSBP) is a steroid hormone transporting protein 
with high affinity for testosterone and estradiol 
[1,2]. It regulates the metabolic clearance rate of 
testosterone in plasma [3,4] and may also be in- 
volved in specific transport of the steroid into 
target cells via receptor-mediated endocytosis [5]. 
Human SBP is a dimeric glycoprotein which binds 
one molecule of steroid and is composed of two 
identical subunits [6,7]. The monomer contains 
373 amino acids, 2 disulfide bonds, and 3 oligosac- 
charide chains [8]. The molecular mass of the 
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dimer based on the amino acid sequence and a 
14% carbohydrate content is 93400 Da [9]. The 
site of biosynthesis remains unknown although 
liver has been suggested as a possibility from 
studies on Hep-G2 cells [lo]. 
Recently, a related protein, the androgen- 
binding protein (ABP) of rat testis, was cloned and 
the cDNA was sequenced [11,12]. Its deduced 
amino acid sequence was found to be 68% 
homologous to that of hSBP [13]. A positive phage 
clone was isolated from a human liver Charon 21A 
cDNA library using rat ABP cDNA as probe (Yar- 
brough, D. and Joseph, D., unpublished). In an 
attempt o gain insight into the site of biosynthesis, 
regulation, gene structure, and the steroid-binding 
site of hSBP, we have isolated and characterized 
the cDNA insert from that clone and we report 
here that it codes for hSBP. 
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2. MATERIALS AND METHODS 
The phage clone was obtained from Drs Yar- 
brough and Joseph. Restriction endonucleases, 
M13mp18 and M13mp19 RF vectors, Klenow frag- 
ment and Tq ligase were purchased from BRL. 
Dideoxysequencing kits were purchased from New 
England Biolab. Radiochemical 32P-nucleotides 
and 35S-dATP were bought from New England 
Nuclear. High titer stock of pure Charon 21A 
recombinant positive phage was prepared as 
described [14] except that the host cell used was E. 
coli LE392. Phage DNA was prepared according 
to published procedure [15], and M13-dideoxy se- 
quencing experiments were as described [ 14,161. 
3. RESULTS 
One positive clone coding for human sex steroid- 
binding protein (SBP) was isolated and plaque 
purified. As shown in fig. 1, the recombinant phage 
released three fragments upon partial EcoRI diges- 
tion having sizes of about 910, 570 and 340 base 
pairs. These were subcloned into phosphatase- 
treated M13mp18 or M13mp19 RF vectors 
previously digested with EcoRI. As shown in fig.2, 
the cDNA sequence contains a coding region (843 
nucleotides) followed by a stop codon (TAA), a 
non-coding region of 20 nucleotides and a poly(A) 
tail of 49 nucleotides. The internal EcoRI site is 
located at the position corresponding to amino 
acid residues Glu-205-Phe-206 (boxed in fig.2). 
The poly(A) tail is preceded by the putative 
polyadenylation signal sequence ATTAAA (boxed 
in fig.2) which is part of the 3 ‘-coding region and 
the termination codon. This is analogous to cDNA 
coding for human blood clotting factor X in which 
ATTAAA is present in the 3 ’ -coding region [ 171 
and the cDNA coding for the P-subunit of human 
chorionic gonadotropin in which the stop codon 
(TAA) is present in the ATTAAA sequence [18]. 
The amino acid sequence deduced from the cDNA 
was in complete agreement with the published se- 
quence [8]. The cDNA clone coded from the 
residue 92 glycine and extended through the 
carboxyl-end 373 histidine. As shown in fig.3, the 
corresponding amino acid was about 67% se- 
quence identity with rat ABP amino acid sequence 
[13] while at the nucleotide level, it achieved higher 
homology (76%) due to several single base 
substitutions (silent mutation). 
Kb> ‘x 12 3 
Fig.1. Analyses of recombinant phage DNA in 0.8% 
agarose containing ethidium bromide with 
corresponding size markers @DNA digested with BstEII 
or HindIII). Lanes: 1, undigested phage clone DNA; 2, 
complete EcoRI digestion of 10 ,,~g of recombinant 
hDNA; 3, partial EcoRI digestion of 1Opg of 
recombinant XDNA. 
Fig.2. Nucleotide and amino acid sequences for human sex steroid-binding protein. Solid triangles represent 
glycosylation sites. The first box represents the internal EcoRI site; the second, the alternating leucine sequence; and 
the third, the polyadenylation signal ATTAAA. 
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92 100 
G P R L D D G R W H Q V E V 
CG GGA CCA CGG CTG GAT GAT GGG AGA TGG CAC CAG GTG GAA GTC 
110 120 
K M E G D S V L L E V D G E E 
AAG ATG aG GGG GAC TCT GTG CTG CTG GAG GTG GAT GGG GAG GAG 
130 
V LR.L R Q V S G P L T S K R 
GTG CTG CGC CTG AGA CAG GTC TCT GGG CCC CTG ACC AGC AAA CGC 
140 150 
H P I M R I A L G G L L F P A 
CAT CCC ATC ATG AGG ATT GCG CTT GGG GGG CTG CTC TTC CCC GCT 
160 
S N L R L P L V P A L D G C L 
TCC AAC CTT CGG TTG CCG CTG GTT CCT GCC CTG GAT GGC TGC CTG 
170 180 
R R D S W L D K Q A E I S A S 
CGC CGG GAT TCC TGG CTG GAC AAA CAG GCC GAG ATC TCA GCA TCT 
190 
A P T S L R S C D V E S N P G 
GCC CCC ACT AGC CTC AGA AGC TGT GAT GTA GAA TCA AAT CCC GGG 
200 210 
IFLPPGTQAEFNLRD 
ATA TTT CTC CCT CCA GGG ACT CAG GCA(GAA[AAT CTC CGA GAC 
220 
I P Q P H A E P W A F S L D L 
ATT CCC CAG CCT CAT GCA GAG CCC TGG GCC TTC TCT TTG GAC CTG 
230 240 
G L K Q A A G S G H L L A L G 
GGA CTC AAG CAG GCA GCA GGC TCA GGC CAC CTC CTT GCT CTT GGG 
250 
T P E N P S W L S L H L Q D Q 
ACA CCA GAG AAC CCA TCT TGG CTC AGT CTC CAC CTC CAA GAT CAA 
260 270 
K V V L S S G S G P G L D L P 
AAG GTG GTG TTG TCT TCT GGG TCG GGG CCA GGGICTG GAT CTT CCC 
280 
L V L G L P L Q L K L S M S R 
CTG GTC TTG GGA CTC CCT CTT CAA CTG AAG CTGIAGT ATG TCC AGG 
I 
290 300 
V V L S Q G S K M K A L A L P 
GTG GTC TTG AGC CAA GGG TCG AAG ATG AAG GCC TTG GCC TTG CCT 
310 
P L G L A P L L N L W A K P Q 
CCT TTA GGC TTG GCT CCC CTC CTT AAC CTC TGG GCC AAG CCT CAA 
320 330 
G R L F L G A L P G E D S S T 
GGG CGT CTC TTC CTT GGG GCT TTA CCA GGA GAA GAC TCT TCC ACC 
340 
S F C L N G L W A Q G Q R L D 
TCT TTT TGC CTG AAT GGC CTT TGG GCA CAA GGT CAG AGG TTG GAT 
350 A 360 
V D Q A L N R S H E I W T H S 
GTG GAC CAG GCC TTG AAC AGA AGC CAT GAG ATC TGG ACT CAC AGC 
A 370 
G T D A S H *** 
T:C C:C C:G A& C:A G:C :T GGC ACT GAC GCT TCC C.@ji?iC 
TCCACCTTAGAACCCCA4g 
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Fig.3. Comparison of the nucleotide and amino acid sequences between hSBP and rat ABP beginning at Gly-92 
[8,12,13]. 
4. DISCUSSION 
In this paper we report the first characterization 
of a cDNA coding for hSBP. Since it was isolated 
from a liver cDNA library, the results provide the 
first experimental evidence that liver is the site of 
SBP biosynthesis. Furthermore, we have recently 
detected the presence of mRNA for SBP in human 
liver by RNA dot blot and Northern blot analyses 
(unpublished). The results, however, do not 
necessarily mean that the liver is the only site of 
biosynthesis. 
The cDNA clone codes for 75% of the hSBP 
amino acid sequence and is in complete agreement 
with it. The previously reported 68% homology at 
the amino acid level between rat ABP and hSBP 
408 
[13] translates to a 76% homology at the 
nucleotide level due to the presence of silent muta- 
tions. The data strongly suggest that the two pro- 
teins have arisen from a common ancestral gene. 
Similarity between those two proteins emphasizes 
the importance of determining the extent of 
homology between hABP and hSBP which we 
have postulated to be very similar if not identical 
[9]. The information will be important for defining 
their relationship and provides answers as to why 
they exist in different compartments. We have 
recently found that the hSBP sequence is 
homologous to the carboxyl-terminal domain 
(residues 249-635) of human protein S [19], a 
vitamin K-dependent cofactor [20] involved in 
blood coagulation (manuscript in preparation). 
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Although much has been learned in recent years 
about the chemical structure of hSBP, its 
physiological role remains unclear. The definition 
of that role is now likely through the availability of 
cDNA probes which will allow cloning of the gene 
and description of its genomic structure and 
regulation. As a result it is hoped that new ap- 
proaches toward solution of clinical disorders 
associated with abnormal evels of plasma SBP will 
be found. Furthermore, site-directed mutagenesis 
of the cDNA for SBP will permit the identification 
of amino acid residues involved in steroid binding. 
For instance, the cDNA we describe in this report 
contains the coding region for the alternating 
leucine sequence located at positions 267-281 
(boxed in fig.2) which we believe can participate in 
steroid binding [8,9]. That hypothesis can now be 
tested by expressing the wild type as well as the 
mutated clones. In addition, since the clone does 
not have the coding sequence containing the only 
tyrosine residue in the molecule (Tyr-57), we will 
be able to test whether or not that residue is in- 
volved in steroid binding. 
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